Top Markets
#1 ADO Protocol ADO Protocol +328.85%
#2 Tutorial Tutorial +56.73%
#3 GoPlus Security GoPlus Security +53.03%
#4 Nockchain Nockchain +49.31%
#5 The Black Bull The Black Bull +36.28%
#6 Starpower Starpower +34.09%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.52%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +17.01%
#10 Verus Coin Verus Coin +16.19%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
Rank in Stocks #32815
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
Share Price
$2.22
Market Cap
$9.03M
Change (1 day)
-3.13%
Change (1 year)
-21.92%
Country
JP
Trade PhoenixBio Co., Ltd. (6190)

Category

Healthcare
P/B ratio for PhoenixBio Co., Ltd. (6190)
P/B ratio as of 2026 TTM: 0
According to PhoenixBio Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for PhoenixBio Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE